CHNC China Infrastructure Construct

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings

HOUSTON, TX, April 24, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, today unveiled the rebranding of its identity, including a new logo as part of its strategy to better reflect CBIH’s focus, medical purpose, and vision for the future.

Starting today, the company has officially begun the process of changing all its digital content, including old logos, websites, videos, advertising, products, and marketing descriptions. This implicates communication with educational and pharmaceutical partners, allies, and e-commerce distributors around the world. By the end of July, the company will strive to have finished the process.

"With a clear goal of helping patients and being part of the development of medicine, we visualized our company as an infinite world where the points need to be connected; nature should connect with science, people should connect with medicine, and business could be connected to all of these points. The rebranding of our firm is rooted in our company’s heritage, as well our new logo better reflects our focus on the near future of medicine," says CBIH’s Research Director Doctor Jennifer Salguero, Ph.D. in Science, University of São Paulo, Brazil.

This rebrand marks a major milestone for our operations, to dispel doubts concerning the location and business of the company, which works with clinical trials, sleep studies, and cannabis education from its office in Houston, Texas. In addition, CBIH´s management wishes to reassure its students, clients, partners, and distributors that these changes will not represent any inconveniences. Thus, our company unequivocally reaffirms to continue to invest the time, human resources, and investment dollars needed to improve the quality of life of thousands of people by continuing to create non-traditional medicine in a traditional world.

To learn more visit:

For more information contact us at:

817/528-2475 for English

214/733-0868 for Spanish



EN
24/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

Cannabis Bioscience International Holdings Announces Effectiveness of ...

Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer or sal...

 PRESS RELEASE

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebrandi...

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company that specializes in clinical trials and cannabinoids education, proudly announces the launch of its new website as a part of its bold rebranding strategy. The new web page better represents the company’s values and vision, predominantly in the areas of research and production of cannabis as me...

 PRESS RELEASE

FINRA Announces Approval for Corporate Name Change From China Infrastr...

FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA (Financial Industry Regulatory Authority, Inc.) has approved the corporate name change from “China Infrastructure Construction Corp...

 PRESS RELEASE

CBIH Announces the Completion of the “Phase of Research and Discovery"...

CBIH Announces the Completion of the “Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project HOUSTON, TX, May 01, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, announces the completion of the stage “research and discovery” on the strategic framework to develop future clinical trials of the effectiveness of cannabinoids in the treatment of Cancer. In this phase of target identification and validation, CBIH’s scientific team has developed molecular biology data analysis for exploring targets and biomark...

 PRESS RELEASE

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabi...

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings HOUSTON, TX, April 24, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, today unveiled the rebranding of its identity, including a new logo as part of its strategy to better reflect CBIH’s focus, medical purpose, and vision for the future. Starting today, the company has officially begun the process of changing all its digital content, including old logos, websites, videos, advertising, products, and marketing descriptions. Th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch